SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.87-2.3%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brander who wrote (30870)4/8/2009 7:54:24 PM
From: Arthur Radley   of 52153
 
Brad, Thanks for the input....should they even get FDA approval, addicts would figure out a way to get around the minor obstacle presented with this formulation.

Considering I went to cash today in my managed account, only keeping the bond portfolio, I don't know why I even asked about KG. IMO, every sign coming out of Washington is indicating that we have some major barriers coming up. Delaying the planned release for the criteria of rating the toxic assets, and my just finish reading William Cohan's "House of Cards" should send a shiver up everyone's spine when it comes to trusting Wall Street. The saga of Bear Stearns as told by Cohan is the classic tale of hubris, considering they were getting ready to release a Q report where they would state they had $17.3 billion dollars in cash on hand, whereas, 10 later days later the company no longer existed. Cohan's book within just the first 20 pages has one glaring mistake about one individual, a person that a junior league fact checker should have noted, it still is a very revealing take on the real character flaws in the BS leadership team.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext